Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 50023102
TargetProgrammed cell death 1 ligand/protein 1(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetProgrammed cell death 1 ligand/protein 1(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetProgrammed cell death 1 ligand/protein 1(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetProgrammed cell death 1 ligand/protein 1(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetProgrammed cell death 1 ligand/protein 1(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetHepatitis A virus cellular receptor 2(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetStromal cell-derived factor 1(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetHepatitis A virus cellular receptor 2(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetHepatitis A virus cellular receptor 2(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetNicotinamide phosphoribosyltransferase(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetHepatitis A virus cellular receptor 2(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetHepatitis A virus cellular receptor 2(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetV-type immunoglobulin domain-containing suppressor of T-cell activation(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Ligand Info
TargetHepatitis A virus cellular receptor 2(Human)
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL
Wenzhou Medical University Lishui Hospital
Curated by ChEMBL


























